The Journal of Pediatrics
Volume 132, Issue 5 , Pages 790-794, May 1998

Diabetic retinopathy in pediatric patients with type-1 diabetes: Effect of diabetes duration, prepubertal and pubertal onset of diabetes, and metabolic control☆☆★★

Received 4 July 1997; received in revised form 30 September 1997 and 2 December 1997; accepted 3 December 1997.

Abstract 

Objective: The objective of this study was to determine the contribution of prepubertal and pubertal onset and duration of diabetes to the development of diabetic retinopathy. Study design: A total of 1391 standardized fundus examinations (stereo fundus-photography) were performed in 441 children or adolescents with type-1 diabetes (median age 15.5 years, median duration of diabetes 6.3 years). Results: Mild nonproliferative retinopathy was present in 72 patients (median age 19.9 years). Life table analysis revealed a median duration of diabetes until retinopathy was first diagnosed at 16.6 years (95% confidence interval: 15.3 to 18.3). Patients were stratified according to diabetes onset before or in puberty (≥10.4 years in girls, ≥12.2 years in boys). In children with a prepubertal onset of diabetes, retinopathy occurred after a pubertal duration of 10.9 years compared with 15.1 years in children with onset of diabetes in puberty (p < 0.01), demonstrating the additional risk conveyed by the prepubertal years of diabetes. Long-term metabolic control had a significant influence on the prevalence of retinopathy: patients with a median HbA1c ≥7.5% had development of retinopathy on average after 15.5 years compared with 18.3 years in patients with lower HbA1c values (p < 0.05). Conclusion: Both prepubertal and pubertal duration of diabetes are relevant for the development of background retinopathy. Good metabolic control should be attempted irrespective of age. (J Pediatr 1998;132:790-4)

Abbreviations:  DCCT , Diabetes Control and Complications Trial

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 From the Department of Pediatrics and the Department of Ophthalmology, University of Ulm, Germany.

☆☆ Financial support for Dr. Holl was available from the German Ministry of Health, the regional government of Baden-Württemberg, the German Diabetes Association, and the Dr. Heinz Bürger-Büsing-Fund from the Association of Diabetic Children and Adolescents, Kaiserslautern.

 Reprint requests: P. D. Reinhard W. Holl, MD, University Children's Hospital, Prittwitzstr. 43, D-89070 Ulm / Germany.

★★ 9/21/87971

PII: S0022-3476(98)70305-1

The Journal of Pediatrics
Volume 132, Issue 5 , Pages 790-794, May 1998